...
首页> 外文期刊>Archives of Biochemistry and Biophysics >Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes
【24h】

Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes

机译:人肝微粒体中细胞色素P450 2C19、2C9和3A4引起的孕酮和睾酮羟基化

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Roles of human cytochrome P450 (P450 or CYP) 2C9, 2C19, and 3A4 in the oxidation of progesterone and testosterone were studied in recombinant P450 enzymes and in human liver microsomes. In vitro inhibition experiments showed that progesterone and its 17 alpha- and 21-hydroxylated metabolites and 11-deoxycortisol suppressed the CYP2C19-dependent R-warfarin 7-hydroxylation activities, with progesterone being the most active, These steroid chemicals also inhibited CYP2C9-dependent S-warfarin 7-hydroxylation activities though lesser extents seen with those in CYP2C19 enzyme. Progesterone was found to be a competitive inhibitor of CYP2C19 and CYP2C9 in human liver microsomes. Recombinant CYP2C19 catalyzed progesterone to form 21-hydroxyprogesterone as a major product and 16 alpha- and 17 alpha-hydroxyprogesterone as minor products. CYP2C9 also had progesterone 21-hydroxylation activities, although the activities were lower than those catalyzed by CYP2C19. V-max/K-m ratios for the progesterone 21-hydroxylation activity of CYP2C19 were determined to be 13- and 32-fold higher than those of CYP2C9 and 3A4, respectively. CYP3A4 oxidized progesterone to form 16 alpha-, 6 beta-, and 2 beta-hydroxyprogesterone as major products and al-hydroxyprogesterone as a minor product, but did not produce detectable levels of 17 alpha-hydroxyprogesterone. Immunoinhibition experiments suggested that anti-CYP2C9 (which inhibits both CYP2C9 and CYP2C19 catalytic activities) suppressed the progesterone 21-hydroxylation activities catalyzed by liver microsomes of humans and monkeys and that anti-CYP2C11 inhibited the progesterone 21-hydroxylation activities catalyzed by liver microsomes of male rats. CYP2C19 was also found to oxidize testosterone at 17-position to form androstenedione. Androstenedione formation catalyzed by liver microsomes of humans and monkeys and of male rats was suppressed by anti-CYP2C9 and anti-CYP2C11, respectively. These results suggest that CYP2C19 plays important roles in the oxidation of progesterone and testosterone in human liver microsomes, although the physiological significance of these metabolic pathways remains unclear, CYP2C9 may have some, but lesser extent than those by CYP2C19, of the catalytic roles for the metabolism of progesterone and testosterone by human liver microsomes. (C) 1997 Academic Press.
机译:在重组P450酶和人肝微粒体中研究了人类细胞色素P450(P450或CYP)2C9、2C19和3A4在孕酮和睾酮氧化中的作用。体外抑制实验表明,孕酮及其17种α-和21-羟基化代谢产物和11-脱氧皮质醇可抑制CYP2C19依赖的R-华法林7-羟基化活性,其中黄体酮最活跃。这些类固醇化合物还抑制CYP2C9依赖的S -华法林7-羟基化活性,但程度较CYP2C19酶低。发现黄体酮是人肝微粒体中CYP2C19和CYP2C9的竞争性抑制剂。重组CYP2C19催化黄体酮形成主要产物21-羟基孕酮,副产物16α-和17α-羟基孕酮。 CYP2C9也具有孕酮21-羟化活性,尽管该活性低于CYP2C19催化的活性。 CYP2C19的孕酮21-羟化活性的V-max / K-m比分别比CYP2C9和3A4高13-和32倍。 CYP3A4氧化孕酮形成16个α-,6个β-和2个β-羟基孕酮作为主要产物,形成α-羟基孕酮作为次要产物,但未产生可检测水平的17个α-羟基孕酮。免疫抑制实验表明,抗CYP2C9(同时抑制CYP2C9和CYP2C19的催化活性)抑制了人和猴肝微粒体催化的孕酮21-羟化活性,而抗CYP2C11抑制了肝微粒体催化的黄体酮21-羟化活性。大鼠。还发现CYP2C19在17位氧化睾丸激素形成雄烯二酮。抗CYP2C9和抗CYP2C11分别抑制人,猴和雄性大鼠肝微粒体催化的雄烯二酮形成。这些结果表明CYP2C19在人肝微粒体的孕酮和睾丸酮的氧化中起重要作用,尽管这些代谢途径的生理学意义仍不清楚,但CYP2C9的催化作用可能比CYP2C19的催化作用小,但程度较CYP2C19小。人肝微粒体代谢孕酮和睾丸激素(C)1997学术出版社。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号